These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 213182)

  • 1. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential immunogens in human pertussis: the role of fimbriae.
    Preston NW
    Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studies.
    Tiru M; Askelöf P; Granström M; Hallander H
    Dev Biol Stand; 1997; 89():239-45. PubMed ID: 9272356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
    Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
    Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
    Niinikoski V; Barkoff AM; Mertsola J; He Q
    Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.
    Preston NW; Surapatana N; Carter EJ
    J Hyg (Lond); 1982 Feb; 88(1):39-46. PubMed ID: 6276465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
    Blaskett AC; Cox JC
    Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002-2014: detection of a genetic shift.
    Shuel M; Lefebvre B; Whyte K; Hayden K; De Serres G; Brousseau N; Tsang RS
    Can J Microbiol; 2016 May; 62(5):437-41. PubMed ID: 26910633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
    Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
    J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
    Knowles K; Lorange M; Matthews RC; Preston NW
    Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serotyping of recently isolated strains of Bordetella pertussis. II. Disparity of agglutination titers of patients' sera between antigens prepared from the Maeno and recently isolated strains (author's transl)].
    Sekiya K; Yamada M; Takamiya A; Nakase Y
    Nihon Saikingaku Zasshi; 1979 Nov; 34(6):827-35. PubMed ID: 231129
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
    Preston A
    Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.